Ultragenyx Pharmaceutical Inc is a pioneering biopharmaceutical firm dedicated to advancing healthcare for those facing rare and ultra-rare genetic diseases globally. With a portfolio that includes Crysvita for X-linked hypophosphatemia, Mepsevii for Mucopolysaccharidosis VII, Dojolvi for long-chain fatty acid oxidation disorders, and Evkeeza for homozygous familial hypercholesterolemia, Ultragenyx is at the forefront of developing innovative treatments. Additionally, the company is exploring gene therapies and monoclonal antibodies for various genetic conditions, demonstrating its commitment to transforming patient lives through science. Founded in 2010 and based in Novato, California, Ultragenyx collaborates with leading healthcare and research institutions to fulfill its mission.
Pre-Market Stock Futures: After a volatile start to the week, futures are trading lower on Tuesday. Markets had plummeted early Monday before the opening bell, only to stage a massive turnaround following…
Wednesday's top analyst upgrades and downgrades included Allstate, Archer Daniels Midland, Avis Budget, Baidu, Centene, Lemonade, Melco Resorts & Entertainment, Palantir Technologies, Peabody Energy, Philip Morris, Shopify and Zscaler.
Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Apple, AT&T, Cenovus Energy, Dollar General, Dynatrace, FedEx, Molson Coors Beverage, NiSource, Uber Technologies and Vale.
Thursday's top analyst upgrades and downgrades included Albertsons Companies, Alphabet, Apple, Coinbase Global, Danaher, Enphase Energy, GE HealthCare Technologies, General Electric, McDonald's, Microsoft, PulteGroup and Tesla.
Friday's top analyst upgrades and downgrades included AMC Entertainment, CNH Industrial, Kala Pharmaceuticals, Opendoor Technologies, Tesla and TG Therapeutics.
Thursday's additional analyst upgrades and downgrades were on Alkermes, Altice USA, Fisker, Freshpet, Lincoln National, Maravai LifeSciences and more.
Friday's top analyst upgrades and downgrades included Altice USA, Apple, Colgate-Palmolive, Marathon Petroleum, Mastercard, Medtronic, Meta Platforms, Nike, Prologis, Realty Income, SLM, Tenaris and Visa.
Tuesday's top analyst upgrades and downgrades included Canopy Growth, Constellation Brands, Equifax, FedEx, Franklin Resources, Micron Technology, Paramount Global, RH and T-Mobile.
Wednesday afternoon's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Constellation Energy, Edwards Lifesciences, Host Hotels & Resorts, Johnson & Johnson and Magna International.
Friday afternoon's top analyst upgrades and downgrades included Affirm, AstraZeneca, Block, CVS, Kellogg and more.
Biotechnology was a huge laggard last year, but Truist Securities is out with its five top picks for 2022 that could see some sensational performance this year. Portfolio managers favor these inexpensive…
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Nvidia, SeaWorld, Wells Fargo and Zoom Video.
Tuesday’s top analyst upgrades and downgrades included Coursera, CSX, Carvana, FedEx, Fox, Marathon, Petro China, Planet Fitness, Regeneron and Rackspace.
Analyst upgrades and downgrades seen Friday afternoon were on Capital One, Diageo, Wells Fargo and more.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Allstate, Booking, CyberArk and Hilton.
